Literature DB >> 25637166

Aptamers as a novel tool for diagnostics and therapy.

Onat Kadioglu1, Anna Helena Malczyk, Henry Johannes Greten, Thomas Efferth.   

Abstract

Aptamers are short single-stranded DNA or RNA oligonucleotides that are capable of binding small molecules, proteins, or nucleotides with high specificity. They show a stable conformation and high binding affinity for their target molecules. There are numerous applications for aptamers in biotechnology, molecular diagnostics and targeted therapy of diseases. Their production is cheap, and they generally display lower immunogenicity than monoclonal antibodies. In the present review, we give an introduction to the preparation of aptamers and provide examples for their use in biotechnology, diagnostics and therapy of diseases.

Mesh:

Substances:

Year:  2015        PMID: 25637166     DOI: 10.1007/s10637-015-0213-y

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  57 in total

Review 1.  Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy.

Authors:  Michael Famulok; Jörg S Hartig; Günter Mayer
Journal:  Chem Rev       Date:  2007-08-23       Impact factor: 60.622

Review 2.  Aptamers: a new class of oligonucleotides in the drug discovery pipeline?

Authors:  Eric Dausse; Sonia Da Rocha Gomes; Jean-Jacques Toulmé
Journal:  Curr Opin Pharmacol       Date:  2009-08-28       Impact factor: 5.547

3.  Isolation of a fluorophore-specific DNA aptamer with weak redox activity.

Authors:  C Wilson; J W Szostak
Journal:  Chem Biol       Date:  1998-11

4.  Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.

Authors:  Shawn E Lupold; Brian J Hicke; Yun Lin; Donald S Coffey
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

5.  Inhibition of thrombin activity with DNA-aptamers.

Authors:  A B Dobrovolsky; E V Titaeva; S G Khaspekova; V A Spiridonova; A M Kopylov; A V Mazurov
Journal:  Bull Exp Biol Med       Date:  2009-07       Impact factor: 0.804

6.  In vivo properties of an anti-GnRH Spiegelmer: an example of an oligonucleotide-based therapeutic substance class.

Authors:  Britta Wlotzka; Susanne Leva; Bernd Eschgfäller; Jens Burmeister; Frank Kleinjung; Christine Kaduk; Peter Muhn; Holger Hess-Stumpp; Sven Klussmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-17       Impact factor: 11.205

7.  Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy.

Authors:  Jiehua Zhou; Haitang Li; Shirley Li; John Zaia; John J Rossi
Journal:  Mol Ther       Date:  2008-05-06       Impact factor: 11.454

8.  Internal 32P-labeling of L-deoxyoligonucleotides.

Authors:  Christian Frauendorf; Felix Hausch; Ingo Röhl; Andrea Lichte; Stefan Vonhoff; Sven Klussmann
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

9.  In vitro selection of RNA aptamers against the HCV NS3 helicase domain.

Authors:  Fumiko Nishikawa; Kohei Funaji; Kotaro Fukuda; Satoshi Nishikawa
Journal:  Oligonucleotides       Date:  2004

Review 10.  Chimeric aptamers in cancer cell-targeted drug delivery.

Authors:  Jagat R Kanwar; Kislay Roy; Rupinder K Kanwar
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-09-28       Impact factor: 8.250

View more
  6 in total

1.  Peptide aptamer identified by molecular docking targeting translationally controlled tumor protein in leukemia cells.

Authors:  Onat Kadioglu; Thomas Efferth
Journal:  Invest New Drugs       Date:  2016-03-14       Impact factor: 3.850

Review 2.  Aptamer-Based Screens of Human Body Fluids for Biomarkers.

Authors:  Dania Albaba; Sanam Soomro; Chandra Mohan
Journal:  Microarrays (Basel)       Date:  2015-09-22

3.  Development of a DNA Aptamer for Screening Neisseria meningitidis Serogroup B by Cell SELEX

Authors:  Kimia Mirzakhani; Seyed Latif Mousavi Gargari; Iraj Rasooli; Samaneh Rasoulinejad
Journal:  Iran Biomed J       Date:  2018-05-01

Review 4.  Oligonucleotide aptamers: potential novel molecules against viral hepatitis.

Authors:  Mina Mirian; Hossein Khanahmad; Leila Darzi; Mansour Salehi; Hojjat Sadeghi-Aliabadi
Journal:  Res Pharm Sci       Date:  2017-04

Review 5.  Therapeutic applications of nucleic acid aptamers in microbial infections.

Authors:  Shima Afrasiabi; Maryam Pourhajibagher; Reza Raoofian; Maryam Tabarzad; Abbas Bahador
Journal:  J Biomed Sci       Date:  2020-01-03       Impact factor: 8.410

6.  Designing of peptide aptamer targeting the receptor-binding domain of spike protein of SARS-CoV-2: an in silico study.

Authors:  Arpita Devi; Nyshadham S N Chaitanya
Journal:  Mol Divers       Date:  2021-01-02       Impact factor: 3.364

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.